During the coronavirus crisis, doctors and healthcare workers are giving absolutely everything in the world’s fight against the epidemic which has claimed more than 6.2 lakh lives globally. There are over 15 million confirmed cases of coronavirus and over 9 million people have recovered from the deadly outbreak.
Without even caring about their lives, doctors and healthcare workers are working all day without taking as rest to save people’s lives. There are absolutely no words to explain their dedication to work.
Besides doctors, health care workers, researchers around the world also deserve our praises as they are trying to determine smart and effective ways to detect COVID-19.
In a significant development, India has developed a vaccine to prevent the spread of coronavirus. India is all set to conduct Human clinical trials for the Covid-19 vaccine.
The All India Institute of Medical Sciences (AIIMS) in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate ‘Covaxin’ on Monday.
AIIMS Director Dr Randeep Guleria said the trial will be conducted in three phases. A total of 1,125 samples have been collected, which will be used for trials in the first two phases, he added.
“Phase 1 vaccine trial will be conducted on healthy people aged 18-55 years who have no co-morbidity. A total of 1125 samples have been collected of which 375 people will be studied in the first phase and 750 people between 12-65 years will be studied in the second phase,” said Guleria.
“To test the efficacy and effectiveness of the vaccine a trial will be conducted under phase-3. The trail will be conducted in AIIMS,” he added.
“Launching of vaccine depends on its overall trial, we will have check the effectiveness of the vaccine for at least 6 months. By end of this year or early next year, there are chances that we will have a vaccine,” said Dr Sanjay Rai, Head of Community Medicine Dept, AIIMS, New Delhi.